This multi-dimensional therapeutic potential is reshaping the positioning of GLP-1 drugs as comprehensive metabolic treatments rather than just glucose-lowering agents For instance, Novo Nordisks semaglutide is now marketed as Wegovy specifically for chronic weight management, while Eli Lillys tirzepatide has received FDA approval under the brand name Zepbound for obesity treatment, independent of diabetic status
GLP1-RAs effects on WL are well-established in the general population and in patients with diabetes [49,50,51,52,53]
Yes, patients with well-controlled Hashimoto's thyroiditis on stable levothyroxine therapy can generally use tirzepatide when indicated for type 2 diabetes or obesity management
The reduced overhead of virtual clinics can translate to cost savings for patients, especially those without insurance coverage
staying hydrated with clear fluids
Then, lower your tongue and hold the liquid there without swallowing